|
|
|
Volumn 28, Issue 4, 1996, Pages 2174-2176
|
|
Verapamil improves sandimmune immunosuppression, reducing acute rejection episodes
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
STEROID;
VERAPAMIL;
ADULT;
ANTIHYPERTENSIVE THERAPY;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DRUG BLOOD LEVEL;
EMULSION;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LIVER TOXICITY;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
CYCLOSPORINE;
DRUG ADMINISTRATION SCHEDULE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
INFUSIONS, INTRAVENOUS;
KIDNEY TRANSPLANTATION;
VERAPAMIL;
|
|
EID: 0029830074
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
